Serif Biomedicines

Seawolf

This biotechnology company develops redosable and durable non-viral DNA-based medicines for patients with unmet medical needs.

Typewriter Therapeutics

The company develops RNA-based genetic medicines for patients with cancer, autoimmune conditions and rare genetic diseases.

Beeline Medicines

This clinical-stage biotechnology company develops precision therapies for patients living with autoimmune and inflammatory diseases.

Bluefin Biomedicine

This biotechnology company develops first-in-class antibody medicines for patients with serious inflammatory and oncologic diseases.

Be Biopharma

This company develops engineered B cell medicines to treat patients with hemophilia B, genetic diseases, and cancer.

Epitome Therapeutics

This biotechnology firm develops an epigenome editing platform for programmable gene expression to treat patients with rare genetic and metabolic disorders.

EdiTy Therapeutics

This company develops immune cell delivery platforms to transport therapeutic proteins into diseased cells for patients with cancer and genetic disorders.

Rewrite Therapeutics

This deep-tech company develops DNA writing and genome editing tools for biotechnology firms to treat genetic diseases.